Evofem Biosciences, Inc. Annual Selling and Marketing Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Evofem Biosciences, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2019 to 2023.
  • Evofem Biosciences, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $2.24M, a 2.09% increase year-over-year.
  • Evofem Biosciences, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $10.2M, a 59.2% decline year-over-year.
  • Evofem Biosciences, Inc. annual Selling and Marketing Expense for 2023 was $11.7M, a 73.5% decline from 2022.
  • Evofem Biosciences, Inc. annual Selling and Marketing Expense for 2022 was $44M, a 61.2% decline from 2021.
  • Evofem Biosciences, Inc. annual Selling and Marketing Expense for 2021 was $113M, a 100% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.7M -$32.3M -73.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $44M -$69.2M -61.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $113M +$56.7M +100% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-27
2020 $56.5M +$46.2M +452% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $10.2M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.